Manulife is introducing a new health initiative in the Philippines that offers personalized gut microbiome screening through its collaboration with AMILI, Southeast Asia’s first microbiome insights company.
In the Philippines, this partnership is especially timely. According to the 2025 Asia Care Survey, 82% of Filipinos cite rising healthcare costs as their top concern, and many feel uncertain about their ability to maintain physical and financial well-being in the future. The screening provided by AMILI helps address these anxieties by offering science-backed, preventive care that supports better health outcomes and reduces long-term medical risks.
“At Manulife Philippines, we are focused on delivering innovative solutions that support the evolving health needs of Filipinos,” said Rahul Hora, President and Chief Executive Officer, Manulife Philippines. “This collaboration with AMILI allows us to offer a unique health experience that goes beyond traditional insurance, empowering our customers to take a proactive approach to their health.”
Manulife customers in the Philippines will now be able to access a personalized gut health screening designed specifically for Asian populations. The service includes tailored nutrition recommendations and teleconsultation to help interpret results. This empowers customers to better understand their health and take preventive steps to improve immunity, brain function, heart health and overall longevity. The service also provides a meaningful way to address rising health concerns in the Philippines by showing how Manulife delivers on its promise to support longer, healthier lives—through early detection, personalized care, and preventive action that can help reduce long-term healthcare costs for individuals and the system
“Our goal is to be a true partner in our customers’ health journey—not just by helping them prepare financially, but also by giving them access to tools, services, and support for prevention, care, and overall well-being,” said Grace Mallabo, Chief Health and Product Officer, Manulife Philippines. “By integrating personalized health insights into our offerings, we are helping Filipinos make informed decisions and improve their quality of life.”
AMILI’s screening leverages the region’s largest multi-ethnic gut microbiome database, delivering insights that support digestive health, immunity, mental well-being, and chronic disease prevention.
“We’re proud to support Manulife’s customers in the Philippines with actionable, science-backed health insights,” said Dr. Jeremy Lim, Chief Executive Officer and Co-founder, AMILI. “This partnership is a step forward in making predictive, preventive care more accessible across Southeast Asia.”
This initiative in the Philippines is an expansion of the First-in-Asia Gut Microbiome Screening collaboration between Manulife and AMILI, launched in 2024 in Singapore. It is part of Manulife’s broader strategy to support health and longevity through value-added offerings across Asia, helping customers take control of their health in meaningful ways.
Details on the collaboration between Manulife Philippines and AMILI can be accessed at https://www.manulife.com.ph/services/manulife-move.html.
